Search Results - Isabelle Huys

Emerging Insights into European Markets of Biologics, Including Biosimilars by Steven Simoens, Isabelle Huys

Connect to this object online.

An overview of patents on therapeutic monoclonal antibodies in Europe: are they a hurdle to biosimilar market entry? by Evelien Moorkens, Arnold G. Vulto, Isabelle Huys

Connect to this object online.

Opportunities and Challenges in Cross-Country Collaboration: Insights from the Beneluxa Initiative by Zilke Claessens, Michiel Lammens, Liese Barbier, Isabelle Huys

Connect to this object online.

Past, Current, and Future Cancer Clinical Research Collaborations: The Case of the European Organisation for Research and Treatment of Cancer by Stefanie Broes, Robbe Saesen, Denis Lacombe, Isabelle Huys

Connect to this object online.

Methodological Quality Assessment of Budget Impact Analyses for Orphan Drugs: A Systematic Review by Khadidja Abdallah, Isabelle Huys, Kathleen Claes, Steven Simoens

Connect to this object online.

How to Value Orphan Drugs? A Review of European Value Assessment Frameworks by Alessandra Blonda, Yvonne Denier, Isabelle Huys, Steven Simoens

Connect to this object online.

Informing a European guidance framework on electronic informed consent in clinical research: a qualitative study by Evelien De Sutter, Pascal Borry, Isabelle Huys, Liese Barbier

Connect to this object online.

Time Investment in Drug Supply Problems by Flemish Community Pharmacies by Elfi De Weerdt, Steven Simoens, Minne Casteels, Isabelle Huys

Connect to this object online.

How Can We Optimize the Value Assessment and Appraisal of Orphan Drugs for Reimbursement Purposes? A Qualitative Interview Study Across European Countries by Alessandra Blonda, Yvonne Denier, Isabelle Huys, Pawel Kawalec, Steven Simoens

Connect to this object online.

Economic evaluation of biosimilars for reimbursement purposes - what, when, how? by Evelien Moorkens, Hannah Broux, Isabelle Huys, Arnold G. Vulto, Steven Simoens

Connect to this object online.

Informing Patients about Biosimilar Medicines: The Role of European Patient Associations by Yannick Vandenplas, Steven Simoens, Philippe Van Wilder, Arnold G. Vulto, Isabelle Huys

Connect to this object online.

How do cancer clinicians perceive real-world data and the evidence derived therefrom? Findings from an international survey of the European Organisation for Research and Treatment... by Robbe Saesen, Robbe Saesen, Georgios Kantidakis, Ann Marinus, Denis Lacombe, Isabelle Huys

Connect to this object online.

Views of European Drug Development Stakeholders on Treatment Optimization and Its Potential for Use in Decision-Making by Robbe Saesen, Robbe Saesen, Stéphane Lejeune, Gianluca Quaglio, Denis Lacombe, Isabelle Huys

Connect to this object online.

The impact of policy interventions to promote the uptake of biosimilar medicines in Belgium: a nationwide interrupted time series analysis by Yannick Vandenplas, Steven Simoens, Philippe Van Wilder, Arnold G. Vulto, Isabelle Huys

Connect to this object online.

On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients by Ciska Verbaanderd, Ciska Verbaanderd, Ilse Rooman, Ilse Rooman, Lydie Meheus, Isabelle Huys

Connect to this object online.

The Market of Biopharmaceutical Medicines: A Snapshot of a Diverse Industrial Landscape by Evelien Moorkens, Nicolas Meuwissen, Isabelle Huys, Paul Declerck, Arnold G. Vulto, Steven Simoens

Connect to this object online.

Off-Patent Biologicals and Biosimilars Tendering in Europe-A Proposal towards More Sustainable Practices by Liese Barbier, Steven Simoens, Caroline Soontjens, Barbara Claus, Arnold G. Vulto, Isabelle Huys

Connect to this object online.

Evaluating the benefits of TNF-alfa inhibitor biosimilar competition on off-patent and on-patent drug markets: A Southern European analysis by Teresa Barcina Lacosta, Arnold G. Vulto, Arnold G. Vulto, Isabelle Huys, Steven Simoens

Connect to this object online.

Barriers and Opportunities for Implementation of Outcome-Based Spread Payments for High-Cost, One-Shot Curative Therapies by Sissel Michelsen, Sissel Michelsen, Salma Nachi, Walter Van Dyck, Steven Simoens, Isabelle Huys

Connect to this object online.

Knowledge and perception of biosimilars in ambulatory care: a survey among Belgian community pharmacists and physicians by Liese Barbier, Yannick Vandenplas, Steven Simoens, Paul Declerck, Arnold G. Vulto, Isabelle Huys

Connect to this object online.